Related Experiment Video
Updated: Oct 31, 2025

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
Published on: March 18, 2014
Tumor Microenvironment in Penile Cancer
1Department of Urology, University Hospital Basel, University of Basel, Spitalstrasse 21, 4031, Basel, Switzerland. matthias.walter@usb.ch.
Penile cancer, though rare, has high mortality when metastatic. This review summarizes key factors in its development, including immune markers and proteins, to guide future treatments and improve survival.
Area of Science:
- Oncology
- Immunology
- Pathogenesis
Background:
- Penile cancer is a rare malignancy with significant morbidity and mortality upon metastasis.
- Understanding the molecular and cellular drivers of penile cancer is crucial for developing effective therapies.
Purpose of the Study:
- To provide a comprehensive review of the literature on penile cancer pathogenesis.
- To summarize key players involved in penile cancer development, including laboratory parameters, immune cells, and molecular markers.
- To outline future research directions and ongoing clinical trials.
Main Methods:
- Literature review and synthesis of current research on penile cancer.
- Identification and summary of key factors in penile cancer pathogenesis.
- Overview of clinical trials and potential therapeutic strategies.
Main Results:
- Key players in penile cancer pathogenesis include neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CrP), PD-1/PD-L1, regulatory T cells (Tregs), FoxP3, Ki-67, p53, and pericytes.
- These factors offer potential targets for diagnostic and therapeutic interventions.
- Ongoing clinical trials explore novel approaches to improve patient outcomes.
Conclusions:
- Several biomarkers and cellular players are implicated in penile cancer pathogenesis.
- Further research and clinical trials are essential to translate these findings into improved survival rates for penile cancer patients.
More Related Videos
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy